Status:
COMPLETED
Investigational Drug Versus an Approved Drug in Patients With Osteoarthritis (0663-061)(COMPLETED)
Lead Sponsor:
Organon and Co
Conditions:
Osteoarthritis
Eligibility:
All Genders
50+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare the gastrointestinal tolerability of an investigational drug to an approved drug in the treatment of osteoarthritis during one year treatment period.
Detailed Description
The duration of treatment is 12 months.
Eligibility Criteria
Inclusion
- Osteoarthritis of the knee, hip, hand or spine which requires the use of medications for pain relief
Exclusion
- Known allergies to the study drugs
Key Trial Info
Start Date :
June 27 2002
Trial Type :
INTERVENTIONAL
End Date :
November 1 2003
Estimated Enrollment :
6000 Patients enrolled
Trial Details
Trial ID
NCT00092703
Start Date
June 27 2002
End Date
November 1 2003
Last Update
August 15 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.